rs188208530
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_003690.5(PRKRA):c.784+6A>T variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00515 in 796,824 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0030 ( 0 hom., cov: 22)
Exomes 𝑓: 0.0054 ( 12 hom. )
Consequence
PRKRA
NM_003690.5 splice_donor_region, intron
NM_003690.5 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.0001641
2
Clinical Significance
Conservation
PhyloP100: 0.0420
Genes affected
PRKRA (HGNC:9438): (protein activator of interferon induced protein kinase EIF2AK2) This gene encodes a protein kinase activated by double-stranded RNA which mediates the effects of interferon in response to viral infection. Mutations in this gene have been associated with dystonia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 2-178436139-T-A is Benign according to our data. Variant chr2-178436139-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 425237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-178436139-T-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRKRA | NM_003690.5 | c.784+6A>T | splice_donor_region_variant, intron_variant | ENST00000325748.9 | |||
CHROMR | NR_110204.1 | n.965+2664T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRKRA | ENST00000325748.9 | c.784+6A>T | splice_donor_region_variant, intron_variant | 1 | NM_003690.5 | P1 | |||
CHROMR | ENST00000453026.7 | n.989+2664T>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00299 AC: 248AN: 83058Hom.: 0 Cov.: 22
GnomAD3 genomes
AF:
AC:
248
AN:
83058
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00263 AC: 452AN: 172034Hom.: 1 AF XY: 0.00255 AC XY: 239AN XY: 93564
GnomAD3 exomes
AF:
AC:
452
AN:
172034
Hom.:
AF XY:
AC XY:
239
AN XY:
93564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00540 AC: 3852AN: 713694Hom.: 12 Cov.: 29 AF XY: 0.00516 AC XY: 1866AN XY: 361606
GnomAD4 exome
AF:
AC:
3852
AN:
713694
Hom.:
Cov.:
29
AF XY:
AC XY:
1866
AN XY:
361606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00298 AC: 248AN: 83130Hom.: 0 Cov.: 22 AF XY: 0.00252 AC XY: 103AN XY: 40872
GnomAD4 genome
AF:
AC:
248
AN:
83130
Hom.:
Cov.:
22
AF XY:
AC XY:
103
AN XY:
40872
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | PRKRA: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 04, 2021 | - - |
Dystonia 16 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 04, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at